HB0174S02 (Substitute)
Sex Characteristic Change Treatment Amendments
Introduction
Jan 20
House Rules
Jan 26
House Committee
Jan 27
House Floor Vote
Mar 2
Senate Rules
Feb 6
Senate Committee
Feb 18
Senate 2nd Reading
Feb 25
Senate 3rd Reading
Feb 27
House Concurrence
Mar 2
Governor Signed
Mar 18
This bill amends provisions related to the provision of cross-sex hormones and puberty blockers to minors.
This bill:
AI-generated summary, reviewed by Better Utah staff.
Starting January 28, 2027, this bill expands Utah's existing ban on gender-affirming hormone treatments for minors by prohibiting health care providers from prescribing cross-sex hormones or puberty blockers to any minor who was younger than 16 years old when the bill takes effect or who had not yet begun cross-sex hormone treatment by that date — and it removes a previously required state medical evidence review of these treatments. Minors who are 16 or older and already receiving cross-sex hormones when the bill takes effect may continue treatment until January 2027, after which they also lose access.
Current version: HB0174S02 (Substitute)
Introduction
Jan 20
House Rules
Jan 26
House Committee
Jan 27
House Floor Vote
Mar 2
Senate Rules
Feb 6
Senate Committee
Feb 18
Senate 2nd Reading
Feb 25
Senate 3rd Reading
Feb 27
House Concurrence
Mar 2
Governor Signed
Mar 18
IntroductionJan 20
House RulesJan 26
House CommitteeJan 27
House Floor VoteMar 2
Senate RulesFeb 6
Senate CommitteeFeb 18
Senate 2nd ReadingFeb 25
Senate 3rd ReadingFeb 27
House ConcurrenceMar 2
Governor SignedMar 18
This bill amends provisions related to the provision of cross-sex hormones and puberty blockers to minors.
This bill:
AI-generated summary, reviewed by Better Utah staff.
Starting January 28, 2027, this bill expands Utah's existing ban on gender-affirming hormone treatments for minors by prohibiting health care providers from prescribing cross-sex hormones or puberty blockers to any minor who was younger than 16 years old when the bill takes effect or who had not yet begun cross-sex hormone treatment by that date — and it removes a previously required state medical evidence review of these treatments. Minors who are 16 or older and already receiving cross-sex hormones when the bill takes effect may continue treatment until January 2027, after which they also lose access.
Motion: Favorable Recommendation
Motion: Favorable Recommendation
Governor Signed
Lieutenant Governor's office for filing
House/ to Governor
Executive Branch - Governor
House/ received enrolled bill from Printing
Clerk of the House
House/ enrolled bill to Printing
Clerk of the House
Enrolled Bill Returned to House or Senate
Clerk of the House
Last updated Mar 26, 2026, 9:39 PM